Common stock par value 0.001 per share 1,000,000,000 shares authorized 420,279,879 shares issued and outstanding at june 30, 2026 and december 31, 2025
420,280
420,280
420,280
420,280
Additional paid-in capital
258,475,479
257,043,993
256,179,846
255,163,053
Accumulated other comprehensive loss
-59,803
-59,906
-60,191
-60,327
Accumulated deficit
-265,126,832
-264,144,266
-262,853,812
-261,688,770
Total provectus biopharmaceuticals, inc., stockholders deficit
-6,275,171
-6,724,587
-6,298,737
-6,150,832
Non-controlling interest in subsidiary
-12,393
-6,243
-3,981
-16,178
Total stockholders deficit
-6,287,564
-6,730,830
-6,302,718
-6,167,010
Total liabilities and stockholders deficit
1,473,501
577,580
697,502
419,904
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.